Aso Pharmaceutical Company, Ltd – FDA 483, Sep 8, 2023
Aso Pharmaceutical Company, Ltd. in Kikuchi-Gun, Japan, a contract manufacturer, received a Form FDA 483 with six observations. The inspection revealed significant deficiencies in laboratory controls, including a lack of specifications for impurities and microbial limits, and inadequate investigations into out-of-specification results and complaints. Other issues included undocumented deviations from procedures, insufficient process validation, poor facility maintenance, and a stability program that does not use the marketed container-closure system.
ID · 73fcc33f-ff52-4412-8831-32e50b4021cc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.